Loading...
XMAD
ATRY
Market cap216mUSD
Jul 22, Last price  
2.50EUR
1D
2.46%
1Q
-13.49%
Jan 2017
68.92%
IPO
48.81%
Name

Atrys Health SA

Chart & performance

D1W1MN
XMAD:ATRY chart
P/E
P/S
1.35
EPS
Div yield, %
Shrs. gr., 5y
21.81%
Rev. gr., 5y
33.06%
Revenues
141m
-33.72%
1,079,2731,018,9041,089,6162,865,8865,962,6228,029,4227,294,14314,836,66733,808,000121,014,000158,366,000201,569,000212,743,000141,007,000
Net income
-100m
L+215.65%
681,811336,533320,1981,294,79163,042290,94011,985-104,785-5,548,000-23,197,000-23,147,000-45,590,000-31,774,000-100,296,000
CFO
-2m
L
000409,89501,316,73101,083,498-1,395,9324,694,000-15,434,000-1,093,0002,997,000-1,559,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Atrys Health, S.A., a biomedical enterprise founded in 2007 and based in Madrid, Spain, specializes in providing a range of diagnostic services and medical treatments. Its diagnostic portfolio encompasses areas like pathology, hematology, molecular pathology, and genetics, supplemented by offerings such as diagnostic second opinions, a comprehensive test directory, and support for clinical trials and research & development. The company effectively utilizes telemedicine to deliver its expertise in medical specialties including radiology, cardiology, ophthalmology, and dermatology. Furthermore, Atrys Health administers radiotherapy and is engaged in the development of innovative therapeutic approaches and diagnostic instruments. The organization operated as Althia Health, S.L. before rebranding to Atrys Health, S.A. in May 2016.
IPO date
Jul 22, 2016
Employees
1,928
Domiciled in
ES
Incorporated in
ES

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT